Barbara Leiting

Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors

Margarita García‐Calvo, Erin P. Peterson, Barbara Leiting et al. · Journal of Biological Chemistry · 1998 · 985 citations · Full text

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 808 citations · Full text

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

Diabetes Management, Pharmacological Study, Biochemistry +15

High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System

KellyAnn D. Pryor, Barbara Leiting · Protein Expression and Purification · 1997 · 244 citations

Protein Chemistry, Soluble Protein, Protein Expression +10

Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII

Barbara Leiting, KellyAnn D. Pryor, Joseph K. Wu et al. · Biochemical Journal · 2003 · 181 citations · Full text

Proteomic Technology, Molecular Pharmacology, Catalytic Constants +15